ProAssurance Secures All Regulatory Approvals for The Doctors Company Merger, Sets June 26 Closing
PRA is trading near its 52-week low of $22.79 (8.2% above the low).
Summary
ProAssurance announced it has received all necessary regulatory approvals for its merger with The Doctors Company, with the closing expected on June 26, 2026.
Key Events · M&A and Partnerships · PRA
-
Final Regulatory Approvals Received
As of June 23, 2026, ProAssurance has received approval from all Insurance Regulators, completing all required regulatory clearances for the merger with The Doctors Company.
-
Merger Closing Date Set
The closing of the merger is now expected to occur on June 26, 2026, subject to the satisfaction or waiver of remaining customary closing conditions.
Analysis · PRA · Finance
ProAssurance has announced the receipt of all necessary regulatory approvals for its merger with The Doctors Company, clearing a major hurdle for the transaction. This definitive update removes significant uncertainty surrounding the deal, which has been a long-standing strategic initiative for the company. The setting of a firm closing date for June 26, 2026, signals the imminent completion of the merger, which is a critical development for the company's future structure and operations. This news comes as the stock is trading near its 52-week high, reinforcing positive market sentiment.
At the time of this filing, PRA was trading at $24.65 on NYSE in the Finance sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $22.79 to $24.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.